150 related articles for article (PubMed ID: 23044010)
21. MicroRNA-mediated somatic cell reprogramming.
Kuo CH; Ying SY
J Cell Biochem; 2013 Feb; 114(2):275-81. PubMed ID: 22961769
[TBL] [Abstract][Full Text] [Related]
22. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
Xia X; Chu J; Chen X
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
[TBL] [Abstract][Full Text] [Related]
23. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
Hussein SM; Nagy AA
Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
[TBL] [Abstract][Full Text] [Related]
24. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
25. Cell fate plug and play: direct reprogramming and induced pluripotency.
Chambers SM; Studer L
Cell; 2011 Jun; 145(6):827-30. PubMed ID: 21663788
[TBL] [Abstract][Full Text] [Related]
26. Direct reprogramming 101.
Takahashi K
Dev Growth Differ; 2010 Apr; 52(3):319-33. PubMed ID: 20298260
[TBL] [Abstract][Full Text] [Related]
27. Generation of induced pluripotent stem cells from somatic cells.
Sohn YD; Han JW; Yoon YS
Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
[TBL] [Abstract][Full Text] [Related]
28. Reprogramming cell fate to pluripotency: the decision-making signalling pathways.
Sanges D; Cosma MP
Int J Dev Biol; 2010; 54(11-12):1575-87. PubMed ID: 21305473
[TBL] [Abstract][Full Text] [Related]
29. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Anastasia L; Pelissero G; Venerando B; Tettamanti G
Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
[TBL] [Abstract][Full Text] [Related]
30. Induction of pluripotent stem cells from primordial germ cells by single reprogramming factors.
Nagamatsu G; Kosaka T; Saito S; Honda H; Takubo K; Kinoshita T; Akiyama H; Sudo T; Horimoto K; Oya M; Suda T
Stem Cells; 2013 Mar; 31(3):479-87. PubMed ID: 23255173
[TBL] [Abstract][Full Text] [Related]
31. Transdifferentiation of adipogenically differentiated cells into osteogenically or chondrogenically differentiated cells: phenotype switching via dedifferentiation.
Ullah M; Sittinger M; Ringe J
Int J Biochem Cell Biol; 2014 Jan; 46():124-37. PubMed ID: 24269783
[TBL] [Abstract][Full Text] [Related]
32. [Cell fate switch: lineage reprogramming].
Sun HY; Wang F; Cao WG
Yi Chuan; 2012 Aug; 34(8):985-92. PubMed ID: 22917903
[TBL] [Abstract][Full Text] [Related]
33. Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine.
Sanges D; Lluis F; Cosma MP
Adv Exp Med Biol; 2011; 713():137-59. PubMed ID: 21432018
[TBL] [Abstract][Full Text] [Related]
34. Faithful reprogramming to pluripotency in mammals - what does nuclear transfer teach us?
Maruotti J; Jouneau A; Renard JP
Int J Dev Biol; 2010; 54(11-12):1609-21. PubMed ID: 21404182
[TBL] [Abstract][Full Text] [Related]
35. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A.
Picanço-Castro V; Russo-Carbolante E; Reis LC; Fraga AM; de Magalhães DA; Orellana MD; Panepucci RA; Pereira LV; Covas DT
Stem Cells Dev; 2011 Jan; 20(1):169-80. PubMed ID: 20504151
[TBL] [Abstract][Full Text] [Related]
36. Induced neural lineage cells as repair kits: so close, yet so far away.
Mirakhori F; Zeynali B; Salekdeh GH; Baharvand H
J Cell Physiol; 2014 Jun; 229(6):728-42. PubMed ID: 24242901
[TBL] [Abstract][Full Text] [Related]
37. Chemical reprogramming and transdifferentiation.
Xie X; Fu Y; Liu J
Curr Opin Genet Dev; 2017 Oct; 46():104-113. PubMed ID: 28755566
[TBL] [Abstract][Full Text] [Related]
38. Cell Transdifferentiation: A Challenging Strategy with Great Potential.
Wang F; Li R; Zhang L; Nie X; Wang L; Chen L
Cell Reprogram; 2023 Aug; 25(4):154-161. PubMed ID: 37471050
[TBL] [Abstract][Full Text] [Related]
39. Direct Conversion of Cell Fate and Induced Endothelial Cells.
Han JK; Shin Y; Kim HS
Circ J; 2022 Nov; 86(12):1925-1933. PubMed ID: 34732599
[TBL] [Abstract][Full Text] [Related]
40. Induced neural stem cells: methods of reprogramming and potential therapeutic applications.
Ruggieri M; Riboldi G; Brajkovic S; Bucchia M; Bresolin N; Comi GP; Corti S
Prog Neurobiol; 2014 Mar; 114():15-24. PubMed ID: 24246715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
